| |
|
|
|
Monopar Therapeutics Inc  
|
|
4.89 -0.09 (-0.02%) |
11-30 15:15 |
|
Open: |
5.0293 |
Pre close: |
4.98 |
Target:
|
6.14
|
|
High: |
5.0293 |
Low: |
4.69 |
Resistance:
|
5.26
6.14
|
|
Volume: |
25,290 |
Market Cap: |
56M |
Support:
|
4.65
4.28
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.91
 |
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
4.75  |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
5.72 |
Stochastic Oscillator |
%K(14,3):
|
65.65 |
|
MA(250): |
0.00 |
%D(3): |
64.29 |
|
Average Volume(K) |
3-Month: |
1978
|
52-Week |
High:
|
48.00 |
|
10-Days: |
1458 |
Low: |
4.28 |
|
RSI |
RSI(14):
|
50.43 |
Change(%): |
-81.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.421 |
Return on Equity (ttm) |
-48.7 |
Shares Out. (M) |
10.63 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-29.4 |
Shares Float (M) |
2.49 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
73.46 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.51 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
42 |
|
Book Value (p.s.) |
0.500 |
EBITDA (p.s.) |
0.000 |
P/E |
-11.62 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.78 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.09 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-1.83 |
P/CF |
-12.71 |
|
|
|
|
|
|
